Seronegative autoimmune diseases: A challenging diagnosis

MV Lenti, CM Rossi, F Melazzini, M Gastaldi… - Autoimmunity …, 2022 - Elsevier
Autoimmune diseases (AID) are increasingly prevalent conditions which comprise more
than 100 distinct clinical entities that are responsible for a great disease burden worldwide …

Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases

L Zeng, K Yang, G Yu, W Hao, X Zhu, A Ge… - Cell Death & …, 2024 - nature.com
Autoimmune diseases commonly affect various systems, but their etiology and pathogenesis
remain unclear. Currently, increasing research has highlighted the role of ferroptosis in …

Recent advances on drug delivery nanoplatforms for the treatment of autoimmune inflammatory diseases

J Zhu, W Chen, Y Sun, X Huang, R Chu, R Wang… - Materials …, 2022 - pubs.rsc.org
As one of the current research hotspots, drug release nanoplatforms have great potential in
the treatment of autoimmune inflammatory diseases. At present, most of the drugs used in …

B cells in autoimmune hepatitis: bystanders or central players?

C Schultheiß, S Steinmann, AW Lohse… - Seminars in …, 2022 - Springer
B cells are central for the adaptive immune system to mount successful immune responses
not only as antibody producers but also as regulators of cellular immunity. These …

Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl4-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics …

Q Wang, Z Luo, D Li, J Qin, Z Pan, B Guo, L Deng… - Metabolites, 2022 - mdpi.com
Liver fibrosis is a pathological result of liver injury that usually leads to a pathophysiological
wound healing response. The total alkaloids of Corydalis saxicola Bunting (TACS) have …

Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million …

A Beheshti Maal, MA Shahrbaf, B Sadri… - Journal of Crohn's …, 2024 - academic.oup.com
Abstract Background and Aims Inflammatory bowel disease [IBD] comprises an immune-
mediated group of chronic gastrointestinal disorders. Patients with IBD may experience …

The usefulness of extended inflammation parameters and systemic inflammatory response markers in the diagnostics of autoimmune hepatitis

W Domerecka, A Kowalska-Kępczyńska, I Homa-Mlak… - Cells, 2022 - mdpi.com
(1) Introduction: Autoimmune hepatitis (AIH) is a chronic disease. A persistent autoimmune
reaction in the liver is significantly related to the systemic inflammatory response. Extended …

The many faces and pathologic diagnostic challenges of autoimmune hepatitis

X Zhang, D Jain - Human Pathology, 2023 - Elsevier
Autoimmune hepatitis (AIH) is an immune-mediated chronic inflammatory liver disease,
characterized by hypergammaglobulinemia, the presence of specific autoantibodies, and …

COVID-19 vaccination-related autoimmune hepatitis—a perspective

CM Sergi - Frontiers in Pharmacology, 2023 - frontiersin.org
Autoimmune hepatitis (AIH) is the inflammation of the liver with clear-cut interface hepatitis
and piecemeal necrosis located at the boundary between portal areas and periportal …

[HTML][HTML] Advances in understanding and managing autoimmune hepatitis: a narrative review

V Yadav, R Irfan, S Safdar, V Sunkara, C Ekhator… - Cureus, 2023 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is a chronic liver disease characterized by immune-mediated
destruction of hepatocytes, leading to inflammation and fibrosis. In recent years, significant …